Your browser doesn't support javascript.
loading
Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity.
Ma, Xingzhe; Bi, Enguang; Huang, Chunjian; Lu, Yong; Xue, Gang; Guo, Xing; Wang, Aibo; Yang, Maojie; Qian, Jianfei; Dong, Chen; Yi, Qing.
Affiliation
  • Ma X; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Bi E; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Huang C; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Lu Y; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Xue G; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Guo X; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Wang A; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, China.
  • Yang M; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Qian J; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Dong C; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, China.
  • Yi Q; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH yiq@ccf.org.
J Exp Med ; 215(6): 1555-1569, 2018 06 04.
Article in En | MEDLINE | ID: mdl-29743292
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Differentiation / Cholesterol / Interleukin-9 / CD8-Positive T-Lymphocytes / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Exp Med Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Differentiation / Cholesterol / Interleukin-9 / CD8-Positive T-Lymphocytes / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Exp Med Year: 2018 Document type: Article